Blood Glucose Monitors Market Report, by Brands and Geography – Analysis, Share, Trends, Size & Forecast 2016 – 2025

  • ID: 3939667
  • Report
  • Region: Global
  • AIM Market Insight
1 of 4


  • 3M Healthcare
  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Johnson and Johnson
  • Nipro Diagnostics
  • MORE

These medical devices are specifically used to control or monitor blood glucose level of diabetic patients. Commercially, a wide range of glucose monitoring devices is available which offers better and accurate result of blood glucose level of patients. For example, now manufacturers have developed blood glucose meters that enable to measure glucose level of patients as many times by using different glucose stips. The demand for blood glucose meters is increasing continuously across the globe owing to the rise in diabetic population globally. For example, according to the World Health Organization (WHO), the disease prevalence and incidence of diabetes is increasing at very fast pace in developing as well as developed countries which require proper attention to control the condition. Additionally, the American Diabetes Association (ADA) also projected that around 29.1 million Americans (approximately 9.3% of the U.S. population) had diabetes in 2012, and the number is anticipated to increase in the future period. Thus, the constant increase in the population affected with diabetic will demand proper attention and care to control the disease prevalence. This fact would, in turn, stimulate the uptake of blood glucose monitoring devices, leading to the market growth. Furthermore, increasing demand for automated monitoring devices, rise in patient preference for home blood glucose monitoring and rowing geriatric population drives the market growth. However, high cost and low acceptance of devices in developing countries such as the Middle East and Africa hamper the market growth.

By Brands:
- Freedom Lite
- Breeze
- Contour
- Advocate RediCode
- OneTouch
- Others

Regarding regions, the global blood glucose monitors market is categorized into North America, Asia Pacific (APAC), Europe Middle East & Africa (MEA) and South America (SAM). Among which, North America dominated the global market owing to the rise in diabetic population coupled with increasing demand for blood glucose devices. On the contrary, Asia Pacific is expected to be the fasted growing market due to the increasing investment of global companies in Asia Pacific countries such as India and China.

The global blood glucose monitors market is consolidated in nature. Leading companies like 3M Healthcare, Abbott Laboratories, Medronic, Inc. and GE Healthcare accounted for the largest shareholder of the market. The consistent increase in research and development activities to develop novel and innovative devices helped these companies to record high share of the global market revenue. Other companies such as Entra Health Systems, Nipro Diagnostics, Omron Healthcare, Philips Healthcare, GE Healthcare, F. Hoffmann-La Roche, Johnson and Johnson, among others are also operating in this market.

Note: Product cover images may vary from those shown
2 of 4


  • 3M Healthcare
  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Johnson and Johnson
  • Nipro Diagnostics
  • MORE

1. Blood Glucose Monitors – Market Overview

2. Executive Summary

3. Blood Glucose Monitors – Market Dynamics
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Future Trends

4. Blood Glucose Monitors Market – Industry Analysis
4.1. Value Chain Analysis
4.2. Average Selling Pricing Analysis
4.3. Technology Roadmap

5. Blood Glucose Monitors – Market Landscape
5.1. Market Share Analysis
5.2. Key Innovators

6. Blood Glucose Monitors Market – By Brands:
6.1. Introduction
6.2. Freedom Lite
6.3. Breeze
6.4. Contour
6.5. Advocate RediCode
6.6. OneTouch
6.7. Others

7. Blood Glucose Monitors Market – By Geography:
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Rest of North America
7.3. Europe
7.3.1. France
7.3.2. Germany
7.3.3. Italy
7.3.4. Spain
7.3.5. U.K
7.3.6. Rest of Europe
7.4. Asia Pacific (APAC)
7.4.1. Australia
7.4.2. China
7.4.3. India
7.4.4. Japan
7.4.5. Rest of APAC
7.5. The Middle East & Africa (MEA)
7.5.1. GCC Countries
7.5.2. North Africa
7.5.3. South Africa
7.5.4. Rest of MEA
7.6. South America (SAM)
7.6.1. Brazil
7.6.2. Rest of SAM

8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Company Overview
8.1.2. SWOT Analysis
8.1.3. Key Developments
8.2. 3M Healthcare
8.2.1. Company Overview
8.2.2. SWOT Analysis
8.2.3. Key Developments
8.3. Nipro Diagnostics
8.3.1. Company Overview
8.3.2. SWOT Analysis
8.3.3. Key Developments
8.4. Omron Healthcare
8.4.1. Company Overview
8.4.2. SWOT Analysis
8.4.3. Key Developments
8.5. Philips Healthcare
8.5.1. Company Overview
8.5.2. SWOT Analysis
8.5.3. Key Developments
8.6. GE Healthcare
8.6.1. Company Overview
8.6.2. SWOT Analysis
8.6.3. Key Developments
8.7. F.Hoffmann-La Roche
8.7.1. Company Overview
8.7.2. SWOT Analysis
8.7.3. Key Developments
8.8. Johnson and Johnson
8.8.1. Company Overview
8.8.2. SWOT Analysis
8.8.3. Key Developments

9. Appendix
9.1. Research Methodology
9.2. Abbreviations
9.3. Disclaimer
9.4. Contact Us

Note: Product cover images may vary from those shown
3 of 4


4 of 4

- 3M Healthcare
- Abbott Laboratories
- F. Hoffmann-La Roche
- GE Healthcare
- Johnson and Johnson
- Nipro Diagnostics
- Omron Healthcare
- Philips Healthcare

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown